126 related articles for article (PubMed ID: 7770639)
1. Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats.
Poo JL; Estanes A; Pedraza-Chaverrí J; Cruz C; Uribe M
Ren Fail; 1995 Jan; 17(1):13-20. PubMed ID: 7770639
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.
Poo JL; Feldmann G; Erlinger S; Braillon A; Gaudin C; Dumont M; Lebrec D
Gastroenterology; 1992 May; 102(5):1752-9. PubMed ID: 1568585
[TBL] [Abstract][Full Text] [Related]
3. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
Purucker E; Marschall HU; Winograd R; Matern S
Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
[TBL] [Abstract][Full Text] [Related]
5. Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats.
Ackerman Z; Karmeli F; Amir G; Rachmilewitz D
J Hepatol; 1996 Apr; 24(4):478-86. PubMed ID: 8738735
[TBL] [Abstract][Full Text] [Related]
6. Impaired renal function in obstructive jaundice: enhanced glomerular thromboxane synthesis and effects of thromboxane receptor blockade in bile duct-ligated rats.
Kramer HJ; Schwarting K; Bäcker A
Clin Sci (Lond); 1995 Jan; 88(1):39-45. PubMed ID: 7704998
[TBL] [Abstract][Full Text] [Related]
7. [Chronology of portal hypertension, decreased sodium excretion, and activation of the renin-angiotensin system in experimental biliary cirrhosis].
Poo JL; Estanes A; Pedraza-Chaverrí J; Cruz C; Pérez C; Huberman A; Uribe M
Rev Invest Clin; 1997; 49(1):15-23. PubMed ID: 9229751
[TBL] [Abstract][Full Text] [Related]
8. NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver.
Fiorucci S; Antonelli E; Brancaleone V; Sanpaolo L; Orlandi S; Distrutti E; Acuto G; Clerici C; Baldoni M; Del Soldato P; Morelli A
J Hepatol; 2003 Dec; 39(6):932-9. PubMed ID: 14642608
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD
Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
[TBL] [Abstract][Full Text] [Related]
11. Renal endothelin system in obstructive jaundice: its role in impaired renal function of bile-duct ligated rats.
Kramer HJ; Schwarting K; Bäcker A; Meyer-Lehnert H
Clin Sci (Lond); 1997 Jun; 92(6):579-85. PubMed ID: 9205418
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of the intravenous administration of ursodeoxycholic acid against endotoxemia in rats with obstructive jaundice.
Hori Y; Ohyanagi H
Surg Today; 1997; 27(2):140-4. PubMed ID: 9017991
[TBL] [Abstract][Full Text] [Related]
13. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Poo JL; Feldmann G; Moreau A; Gaudin C; Lebrec D
J Hepatol; 1993 Aug; 19(1):90-4. PubMed ID: 8301049
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Weiglein AH; Lammert F; Marschall HU; Tsybrovskyy O; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2002 Oct; 123(4):1238-51. PubMed ID: 12360485
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid alleviates cholestasis-induced histophysiological alterations in the male reproductive system of bile duct-ligated rats.
Saad RA; Mahmoud YI
Reprod Toxicol; 2014 Dec; 50():87-97. PubMed ID: 25461907
[TBL] [Abstract][Full Text] [Related]
16. Effects of ursodeoxycholic acid, glutamine and polyclonal immunoglobulins on bacterial translocation in common bile duct ligated rats.
Aldemir M; Geyik MF; Kökoğlu OF; Büyükbayram H; Hoşoğlu S; Yağmur Y
ANZ J Surg; 2003 Sep; 73(9):722-6. PubMed ID: 12956789
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents.
Kageyama Y; Ikeda H; Watanabe N; Nagamine M; Kusumoto Y; Yashiro M; Satoh Y; Shimosawa T; Shinozaki K; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Yokota H; Koyama T; Ishimaru K; Okamoto Y; Takuwa Y; Koike K; Yatomi Y
Hepatology; 2012 Oct; 56(4):1427-38. PubMed ID: 22505286
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium.
Lee SS; Girod C; Braillon A; Hadengue A; Lebrec D
Am J Physiol; 1986 Aug; 251(2 Pt 1):G176-80. PubMed ID: 3740260
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of norUDCA and UDCA in obstructive cholestasis in mice.
Fickert P; Pollheimer MJ; Silbert D; Moustafa T; Halilbasic E; Krones E; Durchschein F; Thüringer A; Zollner G; Denk H; Trauner M
J Hepatol; 2013 Jun; 58(6):1201-8. PubMed ID: 23369794
[TBL] [Abstract][Full Text] [Related]
20. Renin and angiotensinogen mRNA expression in the kidneys of rats subjected to long-term bile duct ligation.
Ubeda M; Matzilevich MM; Atucha NM; García-Estañ J; Quesada T; Tang SS; Ingelfinger JR
Hepatology; 1994 Jun; 19(6):1431-6. PubMed ID: 8188173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]